Dogwood Therapeutics, Inc. DWTX
Set alert
1.28 USD +0.05 +4.07%
At close · Oct 30
1.33 +0.05 +3.88%
After hours · Oct 30, 7:48 PM ET
1.28 Day range 1.36
1.11 52-week range 6.82
- YTD
- -69.23%
- 1 year
- -80.75%
- Open
- 1.30
- Prev close
- 1.23
- Mkt cap
- 43.51M
- Vol
- 62.22K
- Avg vol
- 69.79K
- EPS
- 2.20
- P/E
- 0.58
- Div yield
- 0.00%
More statistics
- Low
- 1.28
- High
- 1.36
- Forward P/E
- -0.43
- Beta
- 0.00
- Short ratio
- 0.42
- Inst. own
- 3.24%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.32
- 200-d avg
- 6.07
- 1y target
- 13.83
2Y chart
Events in this range
- Nov 7, 2024Earnings: -2.05; estimate -1.33; surprise -54.14%
Signals (105)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 27, 2026 | 4 days ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 13, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 3, 2026 | 1 month ago |
| RSI: Overbought | Aug 12, 2026 | 2 months ago |
| RSI: Overbought | Aug 5, 2026 | 2 months ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 22, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 6, 2026 | 3 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Jun 26, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 3, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 30, 2026 | 6 months ago |
| RSI: Oversold | Apr 21, 2026 | 6 months ago |
| RSI: Oversold | Apr 16, 2026 | 6 months ago |
| RSI: Oversold | Mar 30, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 24, 2026 | 7 months ago |
| SMA: Bearish | Mar 23, 2026 | 7 months ago |
| SMA: Bullish | Mar 20, 2026 | 7 months ago |
| SMA: Bearish | Mar 18, 2026 | 7 months ago |
| MACD: Buy Signal | Jan 22, 2026 | 9 months ago |
| RSI: Oversold | Jan 7, 2026 | 9 months ago |
| RSI: Oversold | Dec 23, 2025 | 10 months ago |
| SMA: Bearish | Dec 22, 2025 | 10 months ago |
| SMA: Bearish | Dec 22, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 22, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 19, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 18, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 12, 2025 | 10 months ago |
| SMA: Bullish | Dec 11, 2025 | 10 months ago |
| SMA: Bearish | Dec 5, 2025 | 11 months ago |
| MACD: Sell Signal | Dec 5, 2025 | 11 months ago |
| SMA: Bullish | Nov 18, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 18, 2025 | 11 months ago |
| SMA: Bullish | Nov 14, 2025 | 11 months ago |
| SMA: Bearish | Nov 13, 2025 | 11 months ago |
| SMA: Bearish | Nov 13, 2025 | 11 months ago |
| SMA: Bullish | Nov 12, 2025 | 11 months ago |
| SMA: Bullish | Nov 12, 2025 | 11 months ago |
| SMA: Bearish | Nov 5, 2025 | 12 months ago |
| SMA: Bearish | Nov 4, 2025 | 12 months ago |
| MACD: Sell Signal | Nov 4, 2025 | 12 months ago |
| MACD: Buy Signal | Oct 30, 2025 | 1 year ago |
| SMA: Bullish | Oct 23, 2025 | 1 year ago |
| SMA: Bearish | Oct 22, 2025 | 1 year ago |
| SMA: Bullish | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 9, 2025 | 1 year ago |
| RSI: Overbought | Sep 29, 2025 | 1 year ago |
| SMA: Bullish | Sep 26, 2025 | 1 year ago |
| SMA: Bullish | Sep 19, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 19, 2025 | 1 year ago |
| SMA: Bearish | Sep 18, 2025 | 1 year ago |
| SMA: Bullish | Sep 10, 2025 | 1 year ago |
| SMA: Bearish | Sep 9, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 5, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 4, 2025 | 1 year ago |
| SMA: Bullish | Sep 3, 2025 | 1 year ago |
| SMA: Bearish | Sep 2, 2025 | 1 year ago |
| SMA: Bullish | Aug 29, 2025 | 1 year ago |
| SMA: Bearish | Aug 27, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 27, 2025 | 1 year ago |
| SMA: Bearish | Aug 26, 2025 | 1 year ago |
| SMA: Bullish | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 20, 2025 | 1 year ago |
| SMA: Bearish | Aug 19, 2025 | 1 year ago |
| SMA: Bullish | Aug 14, 2025 | 1 year ago |
| SMA: Bearish | Aug 11, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 18, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 16, 2025 | 1 year ago |
| SMA: Bearish | Jul 15, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 8, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 7, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 1, 2025 | 1 year ago |
| SMA: Bearish | Jun 13, 2025 | 1 year ago |
| SMA: Bullish | Jun 12, 2025 | 1 year ago |
| SMA: Bearish | Jun 11, 2025 | 1 year ago |
| SMA: Bullish | Jun 6, 2025 | 1 year ago |
| SMA: Bearish | Jun 5, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 5, 2025 | 1 year ago |
| SMA: Bullish | May 19, 2025 | 1 year ago |
| SMA: Bearish | May 16, 2025 | 1 year ago |
| SMA: Bullish | May 15, 2025 | 1 year ago |
| MACD: Buy Signal | May 14, 2025 | 1 year ago |
| MACD: Sell Signal | May 8, 2025 | 1 year ago |
| SMA: Bearish | May 1, 2025 | 1 year ago |
| SMA: Bullish | Apr 23, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 17, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 21, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 20, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 19, 2025 | 1 year ago |
| SMA: Bearish | Mar 14, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 10, 2025 | 1 year ago |
| SMA: Bullish | Mar 7, 2025 | 1 year ago |
| SMA: Bearish | Feb 21, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 7, 2025 | 1 year ago |
| RSI: Overbought | Jan 23, 2025 | 1 year ago |
| SMA: Bullish | Jan 21, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 15, 2025 | 1 year ago |
Key statistics
- Market cap
- 3.62M
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- -0.43
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.55
- EPS (TTM)
- -6.32
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Shares outstanding
- 1.33M
- Short % of float
- 2.56%
- 50-day average
- 3.32
- 200-day average
- 6.07
Analyst view
Consensus: none
Price target (mean) 13.83 +980.7% upside
Now 1.28
- Target (low)
- 5.00
- Target (mean)
- 13.83
- Target (high)
- 25.00
Ratings (0m) 2 1 buy · 1 hold · 0 sell
- Strong buy1
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
DWTX Revenue — quarterly 0
DWTX Net income — quarterly -11.53M
DWTX EPS — quarterly -0.34
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | -1.33 | -2.05 | -0.72 | -54.14% |
About Dogwood Therapeutics, Inc.
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- dwtx.com
News
- Dogwood Therapeutics Enters Into Securities Subscription Agreement For $5 Investment From CK Life Sciences’ Subsidiary
- Dogwood to Participate in the 2026 Maxim Growth Summit
- Dogwood Announces Completion of Enrollment in Ongoing Halneuron® Phase 2b Trial
- 12 Health Care Stocks Moving In Friday's After-Market Session
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- Dogwood Therapeutics, Inc. (DWTX) Discusses Halneuron and Pipeline Advances for Chemotherapy-Induced Neuropathic Pain Transcript
- Dogwood Therapeutics Nears Phase 2b Readout for Halneuron Neuropathic Pain Treatment
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Dogwood to Host Virtual KOL Event to Discuss Halneuron® for the Treatment of Chemotherapy Induced Neuropathic Pain on September 1, 2026
- Dogwood Therapeutics Q2 EPS $(0.34) Misses $(0.14) Estimate
Your note
Sign in to keep a note on DWTX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DUNCAN GREGORY SCOTT | Chief Executive Officer | Purchase | Aug 16, 2023 | 57,461 |
| PRIDGEN WILLIAM L | Director | Purchase | Aug 20, 2023 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Geode Capital Management, LLC | 1.39% | 18,460 | 50.21K | Sep 29, 2024 |
| Vanguard Group Inc | 1.25% | 16,711 | 45.45K | Sep 29, 2024 |
| UBS Group AG | 1.12% | 14,885 | 40.49K | Sep 29, 2024 |
| HRT Financial LP | 0.49% | 6,526 | 17.75K | Sep 29, 2024 |
| State Street Corporation | 0.32% | 4,226 | 11.49K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.32% | 4,271 | 11.62K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 1.25% | 16,711 | 45.45K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.45% | 5,942 | 16.16K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.17% | 2,294 | 6.24K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.13% | 1,750 | 4.76K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.07% | 880 | 2.39K | Oct 30, 2024 |